<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05628220</url>
  </required_header>
  <id_info>
    <org_study_id>17-083</org_study_id>
    <nct_id>NCT05628220</nct_id>
  </id_info>
  <brief_title>Motion Sickness Desensitization Using VR</brief_title>
  <acronym>SENSORIEL1</acronym>
  <official_title>Evaluation and Countermeasures of Motion Sickness by Virtual Reality Desensitization Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of a virtual reality desensitization protocol on subjects with severe motion&#xD;
      sickness and study of the role of the emotional component on the effectiveness of the&#xD;
      therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Motion sickness is a well-known syndrome, particularly at risk in children, with a maximum&#xD;
      around the age of 12. All people are sensitive to motion sickness in childhood, probably&#xD;
      related to the maturation of certain cognitive functions of a spatial nature, namely the&#xD;
      perception of oneself and one's movements in one's environment. These symptoms regress with&#xD;
      age for a part of the population but a large number of people will remain sensitive to&#xD;
      certain conditions of displacement and generate symptoms that can be extremely disabling and&#xD;
      handicapping in everyday life, particularly for professional activities. For example, some&#xD;
      people can no longer use their car, some can no longer take the boat for professional&#xD;
      activities in restrictive and/or extreme environments (sailors, scientists, workers, etc.).&#xD;
      Behavioral, respiratory or medicinal therapies remain partially effective due to the lack of&#xD;
      sufficient knowledge on the physiopathology of this syndrome classified in the field of&#xD;
      sensory disorders. Very recently, techniques of sensory desensitization by visual stimulation&#xD;
      have appeared, either optokinetic or in virtual reality mimicking the environment that causes&#xD;
      this syndrome. This therapeutic approach seems to give empirically good results but only one&#xD;
      study has shown it with optokinetic stimulation but it is to be evaluated for virtual&#xD;
      reality.&#xD;
&#xD;
      The main objective of the study is therefore to evaluate the effectiveness of a sensory&#xD;
      conflict protocol generated in virtual reality to reduce the severity of motion sickness.&#xD;
      Each subject being his own control. An observational study was then designed to quantify the&#xD;
      effectiveness of this technique carried out in a current way by the physiotherapists in the&#xD;
      form of questionnaires supplemented by a posturographic evaluation of the sensory profile of&#xD;
      the subjects. If the effectiveness is proven, this desensitization protocol could be&#xD;
      optimized and more widely distributed. Furthermore, the analysis of the visuo-dependence&#xD;
      variable (from the sensory profile) will indicate whether the use of a visual stimulus by&#xD;
      virtual reality alone is sufficient or should be combined or compared with desensitization of&#xD;
      other sensory modalities. The use of galvanic vestibular stimulation for the rehabilitation&#xD;
      of vestibular pathologies or training programs based on the resolution of sensory conflicts&#xD;
      could be envisaged in the future.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2018</start_date>
  <completion_date type="Anticipated">February 28, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>one cohort of patients suffering from motion sickness</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>motion sickness severity</measure>
    <time_frame>day 0 (day before the first session of rehabilitation)</time_frame>
    <description>simulator sickness questionnaire (0-64)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>motion sickness severity</measure>
    <time_frame>day 30 (day after the end of rehabilitation)</time_frame>
    <description>simulator sickness questionnaire (0-64)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Emotion</measure>
    <time_frame>day 0 (day before the first session of rehabilitation)</time_frame>
    <description>The State-Trait Anxiety Questionnaire (0-80)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotion</measure>
    <time_frame>day 30 (day after the end of rehabilitation)</time_frame>
    <description>The State-Trait Anxiety Questionnaire (0-80)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Posture</measure>
    <time_frame>day 0 (day before the first session of rehabilitation)</time_frame>
    <description>postural measurement (gravity center ellipse)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Posture</measure>
    <time_frame>day 30 (day after the end of rehabilitation)</time_frame>
    <description>postural measurement (gravity center ellipse)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Motion Sickness</condition>
  <arm_group>
    <arm_group_label>Cohort of motion sickness</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>one group of patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>physiotherapy</intervention_name>
    <description>rehabilitation through using session of virtual reality desensitization</description>
    <arm_group_label>Cohort of motion sickness</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Suffering from motion sickness inducing a functional disability requiring a change in&#xD;
             the mode of travel, or suffering from motion sickness disabling to exercise a leisure&#xD;
             or professional activity involving a mode of locomotion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  History of severe ENT or ophthalmologic pathologies.&#xD;
&#xD;
          -  Chronic treatment with an anticholinergic or anti-histamine medication.&#xD;
&#xD;
          -  Participating in another biomedical research protocol during the same period&#xD;
&#xD;
          -  Person under guardianship or curatorship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>67 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>stephane BESNARD, Md,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>stephane besnard, MD, PhD</last_name>
    <phone>+33677978649</phone>
    <email>stephane.besnard@unicaen.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane BESNARD, MD, PhD</last_name>
      <phone>+33231065332</phone>
      <email>stephane.besnard@unicaen.fr</email>
    </contact>
    <investigator>
      <last_name>Stéphane BESNARD, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin HITIER, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvain MOREAU, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laetitia PLISSON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Frédéric Xavier</name>
      <address>
        <city>Vitrolles</city>
        <zip>13127</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric XAVIER, PhD</last_name>
      <phone>+33231065332</phone>
      <email>frederic.xavier@etu.univ-amu.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://gdrvertige.com/</url>
    <description>topical team motion sickness</description>
  </link>
  <verification_date>August 2022</verification_date>
  <study_first_submitted>September 8, 2022</study_first_submitted>
  <study_first_submitted_qc>November 24, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2022</study_first_posted>
  <last_update_submitted>November 24, 2022</last_update_submitted>
  <last_update_submitted_qc>November 24, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vestibular system</keyword>
  <keyword>posture</keyword>
  <keyword>anxiety</keyword>
  <keyword>nausea</keyword>
  <keyword>motion sickness</keyword>
  <keyword>visually induced motion sickness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motion Sickness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

